Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia
Nozomi Niitsu, Yoshio Honma(National Cancer Center Hospital East), Nobuo Maseki(Saitama Cancer Center), Masanori Umeda(Saitama Cancer Center), Junko Okabe‐Kado(Saitama Cancer Center), Michihiro Nakayama(Asahikawa Medical University), Akiko Sakashita(SHOWA Medical University), Kazuo Motoyoshi(National Defense Medical College), Naoki Wakimoto(SHOWA Medical University)
Cited by 42
Related Papers
1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.
|Proceedings of the National Academy of Sciences|1983|255
Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative
|Journal of Lipid Research|2004|156
Osteoclastogenesis Inhibitory Factor Suppresses Osteoclast Survival by Interfering in the Interaction of Stromal Cells with Osteoclast
|Biochemical and Biophysical Research Communications|1998|124
Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids
|Biochemical and Biophysical Research Communications|1980|120